Back
11 June 2025
Following the launch of the sample re-analysis program for the Olympic Games Rio 2016, the ITA previously reported that the re-analysis of a sample collected by the IOC out-of-competition (OOC) on 27 July 2016 and a sample collected by the IOC in-competition (IC) on 10 August 2016 from Alexandru Spac had returned adverse analytical findings¹ for Dehydrochloromethyltestosterone (DHCMT) metabolite.
DCHMT is a non-specified prohibited substance according to the prohibited list of the World Anti-Doping Agency (WADA) and is prohibited at all times. DHCMT is a derivative of testosterone. It is a synthetically created anabolic steroid which causes rapid growth of the muscles, which in turn leads to high increases in strength performance.
Following the results management process conducted by the ITA, the ITA submitted the matter for adjudication to CAS ADD.
After considering the written submissions and evidence, on 28 May 2025, CAS ADD issued its award holding that the athlete had committed an ADRV for the presence and use of a prohibited substance in accordance with Articles 2.1/2.2 of the IOC Anti-Doping Rules applicable to the Olympic Games Rio 2016 (IOC ADR).
As a result, all competitive results of Alexandru Spac obtained at the Olympic Games Rio 2016 are disqualified including forfeiture of medals, points and prizes. This includes the 5th place finish in the weightlifting men’s -77kg competition.
Parties with a right of appeal may challenge the decision before the appeal division of CAS in accordance with article 12.2 of the IOC ADR.
The matter has been referred to the International Weightlifting Federation (IWF) to determine the applicable consequences under the IWF Anti-Doping Rules.
The ITA will not comment further on this case.
¹ A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.
